Byoung Chul Cho - Dissemin

, Darren W.-T. Lim, Muh-Hwa Yang, Pei-Jen Lou, June Corry, Jin Ching Lin, Guo Pei Zhu, Kyung Hwan Kim, Bin Zhang, Zhiming Li, Ruey-Long Hong, Junice Yi Siu Ng, Ee Min Tan and 4 other authors

Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific

Upload

This paper is made freely available by the publisher.

Su-Jin Choi, Jii Bum Lee

, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho

, Sun Min Lim

Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer

Download from doi.org

Vivek Subbiah

, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux

, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A. Cassier and 9 other authors

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Upload

2023 Ross A. Soo, Byoung Chul Cho

, Joo-Hang Kim, Myung-Ju Ahn, Ki Hyeong Lee, Anastasia Zimina, Sergey Orlov, Igor Bondarenko, Yun-Gyoo Lee, Yueh Ni Lim, Sung Sook Lee, Kyung-Hee Lee, Yong Kek Pang, Chin Heng Fong, Jin Hyoung Kang and 8 other authors

Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis

Upload

Edward B. Garon

, Byoung Chul Cho

, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng-Ta Yang, Luiz Henrique Araujo, Haruhiro Saito, Niels Reinmuth, Nenad Medic, Helen Mann and 4 other authors

Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)

Upload

Byoung Chul Cho

, Jong Seok Lee, Yi-Long Wu, Irfan Cicin, Manuel Cobo Dols, Myung-Ju Ahn, Kristof Cuppens, Rémi Veillon, Ernest Nadal, Josiane Mourão Dias, Claudio Martin, Martin Reck, Edward B. Garon, Enriqueta Felip, Luis Paz-Ares and 10 other authors

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Upload

Jorn Nützinger

, Jii Bum Lee, Jia Li Low, Puey Ling Chia, Silvana Talisa Wijaya, Byoung Chul Cho

, Sun Min Lim, Ross A. Soo

Management of HER2 alterations in non-small cell lung cancer – The past, present, and future

Upload

Daniel S. W. Tan

, Enriqueta Felip

, Gilberto de Castro

, Benjamin J. Solomon

, Alastair Greystoke

, Byoung Chul Cho

, Manuel Cobo, Tae Min Kim

, Sandip Ganguly

, Enric Carcereny, Luis Paz-Ares

, Jaafar Bennouna, Marina Chiara Garassino

, Michael Schenker

, Sang-We Kim and 8 other authors

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

Download from doi.org

Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho

, Baogang Liu, Luis Paz-Ares, Susanna Cheng, Satoru Kitazono, Muthukkumaran Thiagarajan, Jonathan W. Goldman

, Joshua K. Sabari, Rachel E. Sanborn, Aaron S. Mansfield

, Jen-Yu Hung, Michael Boyer, Sanjay Popat and 13 other authors

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Upload

Distributing this paper is prohibited by the publisher

Tae Min Kim, Nicolas Girard, Grace Kah Mun Low, Jianmin Zhuo, Dae Young Yu, Yishen Yang, Maiko Murota, Cindy Thiow Koon Lim, Nora J. Kleinman, Byoung Chul Cho

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy

Upload

Myung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, Byoung Chul Cho

, Shunichi Sugawara, Gabriella Gálffy, Byoung Yong Shim, Nikolay Kislov, Rajnish Nagarkar, Ingel Demedts, Steven J. M. Gans, Dolores Mendoza Oliva, Ross Stewart, Zhongwu Lai, Helen Mann and 2 other authors

Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study

Upload

Myung-Ju Ahn, Byoung Chul Cho

, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Oscar Juan-Vidal

, Sabin Handzhiev, Hiroki Izumi, Jong-Seok Lee, Rafal Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez and 15 other authors

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Upload

Yvonne L. E. Ang, Xiaotian Zhao

, Thanyanan Reungwetwattana, Byoung-Chul Cho

, Bin-Chi Liao, Rebecca Yeung, Herbert H. Loong

, Dong-Wan Kim, James Chih-Hsin Yang, Sun Min Lim, Myung-Ju Ahn, Se-Hoon Lee, Thitiporn Suwatanapongched, Kanchaporn Kongchauy, Qiuxiang Ou and 5 other authors

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

Download from doi.org

Thanyanan Reungwetwattana, Byoung Chul Cho

, Ki Hyeong Lee, Yong Kek Pang, Chin Heng Fong, Jin Hyoung Kang, Yun-Gyoo Lee, Chun Sen Lim, Pongwut Danchaivijitr, Yueh Ni Lim, Youngjoo Lee, Soon Hin How, Sarayut Geater, Sung Sook Lee, Young Joo Min and 7 other authors

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Byoung Chul Cho